These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

401 related articles for article (PubMed ID: 26152845)

  • 1. A novel pathogenic RBP-3 peptide reveals epitope spreading in persistent experimental autoimmune uveoretinitis.
    Boldison J; Khera TK; Copland DA; Stimpson ML; Crawford GL; Dick AD; Nicholson LB
    Immunology; 2015 Oct; 146(2):301-11. PubMed ID: 26152845
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Repertoire analysis and new pathogenic epitopes of IRBP in C57BL/6 (H-2b) and B10.RIII (H-2r) mice.
    Cortes LM; Mattapallil MJ; Silver PB; Donoso LA; Liou GI; Zhu W; Chan CC; Caspi RR
    Invest Ophthalmol Vis Sci; 2008 May; 49(5):1946-56. PubMed ID: 18436827
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of a new epitope of human IRBP that induces autoimmune uveoretinitis in mice of the H-2b haplotype.
    Avichezer D; Silver PB; Chan CC; Wiggert B; Caspi RR
    Invest Ophthalmol Vis Sci; 2000 Jan; 41(1):127-31. PubMed ID: 10634611
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of retinal cellular infiltrate in experimental autoimmune uveoretinitis reveals multiple regulatory cell populations.
    Kerr EC; Raveney BJ; Copland DA; Dick AD; Nicholson LB
    J Autoimmun; 2008 Dec; 31(4):354-61. PubMed ID: 18838247
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Staphylococcal enterotoxin B is involved in aggravation and recurrence of murine experimental autoimmune uveoretinitis via Vbeta8+CD4+ T cells.
    Kohno H; Sakai T; Tsuneoka H; Imanishi K; Saito S
    Exp Eye Res; 2009 Oct; 89(4):486-93. PubMed ID: 19523946
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A new model of autoimmune disease. Experimental autoimmune uveoretinitis induced in mice with two different retinal antigens.
    Caspi RR; Roberge FG; Chan CC; Wiggert B; Chader GJ; Rozenszajn LA; Lando Z; Nussenblatt RB
    J Immunol; 1988 Mar; 140(5):1490-5. PubMed ID: 3346541
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mapping immune responses to mRBP-3 1-16 peptide with altered peptide ligands.
    Guyver CJ; Copland DA; Calder CJ; Sette A; Sidney J; Dick AD; Nicholson LB
    Invest Ophthalmol Vis Sci; 2006 May; 47(5):2027-35. PubMed ID: 16639012
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A new procedure for experimental autoimmune uveitis with small uveitogenic peptides.
    Sery TW; Su YH; Eagle R; Ueda M; Yamamoto N
    Ocul Immunol Inflamm; 2006 Oct; 14(5):277-83. PubMed ID: 17056461
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of Th2-type suppressor T cells among in vivo expanded ocular T cells in mice with experimental autoimmune uveoretinitis.
    Keino H; Takeuchi M; Suzuki J; Kojo S; Sakai J; Nishioka K; Sumida T; Usui M
    Clin Exp Immunol; 2001 Apr; 124(1):1-8. PubMed ID: 11359436
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of a New Epitope of IRBP That Induces Moderate to Severe Uveoretinitis in Mice With H-2b Haplotype.
    Mattapallil MJ; Silver PB; Cortes LM; St Leger AJ; Jittayasothorn Y; Kielczewski JL; Moon JJ; Chan CC; Caspi RR
    Invest Ophthalmol Vis Sci; 2015 Aug; 56(9):5439-49. PubMed ID: 26284549
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evidence for selective accumulation of V beta 8+ T lymphocytes in experimental autoimmune uveoretinitis induced with two different retinal antigens.
    Egwuagu CE; Mahdi RM; Nussenblatt RB; Gery I; Caspi RR
    J Immunol; 1993 Aug; 151(3):1627-36. PubMed ID: 8393049
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of a major pathogenic epitope in the human IRBP molecule recognized by mice of the H-2r haplotype.
    Silver PB; Rizzo LV; Chan CC; Donoso LA; Wiggert B; Caspi RR
    Invest Ophthalmol Vis Sci; 1995 Apr; 36(5):946-54. PubMed ID: 7706044
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of IL-17+ interphotoreceptor retinoid-binding protein-specific T cells in experimental autoimmune uveitis.
    Peng Y; Han G; Shao H; Wang Y; Kaplan HJ; Sun D
    Invest Ophthalmol Vis Sci; 2007 Sep; 48(9):4153-61. PubMed ID: 17724201
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Heterologous epitopes of IRBP protect against autoimmune uveitis induced by the autologous epitope.
    Silver PB; Rizzo LV; Sun B; Chan CC; Wiggert B; Nussenblatt RB; Caspi RR
    J Neuroimmunol; 1998 Aug; 88(1-2):128-36. PubMed ID: 9688334
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Experimental autoimmune uveoretinitis (EAU)-related tissue damage and angiogenesis is reduced in CCL2⁻/⁻CX₃CR1gfp/gfp mice.
    Zhao J; Chen M; Xu H
    Invest Ophthalmol Vis Sci; 2014 Oct; 55(11):7572-82. PubMed ID: 25342612
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevention of experimental autoimmune uveoretinitis by vasoactive intestinal peptide.
    Keino H; Kezuka T; Takeuchi M; Yamakawa N; Hattori T; Usui M
    Arch Ophthalmol; 2004 Aug; 122(8):1179-84. PubMed ID: 15302659
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Carbon monoxide-releasing molecule-A1 (CORM-A1) improves clinical signs of experimental autoimmune uveoretinitis (EAU) in rats.
    Fagone P; Mangano K; Mammana S; Cavalli E; Di Marco R; Barcellona ML; Salvatorelli L; Magro G; Nicoletti F
    Clin Immunol; 2015 Apr; 157(2):198-204. PubMed ID: 25701800
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recruitment of antigen-nonspecific cells plays a pivotal role in the pathogenesis of a T cell-mediated organ-specific autoimmune disease, experimental autoimmune uveoretinitis.
    Caspi RR; Chan CC; Fujino Y; Najafian F; Grover S; Hansen CT; Wilder RL
    J Neuroimmunol; 1993 Sep; 47(2):177-88. PubMed ID: 8370769
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Experimental autoimmune uveoretinitis in mice (Biozzi ABH and NOD) expressing the autoimmune-associated H-2A(g7) molecule: identification of a uveitogenic epitope.
    Hankey DJ; Nickerson JM; Donoso LA; Lightman SL; Baker D
    J Neuroimmunol; 2001 Aug; 118(2):212-22. PubMed ID: 11498256
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Contribution of CD4+CD25+ T cells to the regression phase of experimental autoimmune uveoretinitis.
    Sun M; Yang P; Du L; Zhou H; Ren X; Kijlstra A
    Invest Ophthalmol Vis Sci; 2010 Jan; 51(1):383-9. PubMed ID: 19696173
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.